Solventum stock

SOLV · NYSE · USD

Compare Solventum
$84.50Change from previous close: −1.52%Absolute change: −$1.30

Close · November 20, 2026

Price history

+6.28% over the period

1 year: from $79.51 (November 20, 2025) to $84.50 (November 20, 2026), +6.28%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026$84.50
October 30, 2026$81.33
September 30, 2026$88.15
August 31, 2026$91.06
July 31, 2026$85.44
June 30, 2026$77.15
May 29, 2026$74.95
April 30, 2026$67.36
March 31, 2026$65.30
February 27, 2026$74.20
January 30, 2026$76.97
December 31, 2025$79.24
November 28, 2025$85.26
November 20, 2025$79.51

At a glance

  • The company

    Develops and sells medical devices, dental products, and healthcare software solutions for wound care, surgical supplies, orthodontics, and clinical documentation

  • Latest results

    Quarter to September 30, 2026 · EPS $1.45 (estimate $1.62)

TickerLandia's take on Solventum

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$62.38
52-wk high$94.16

−10.26% from the 52-week high

Analysts · 15 analysts

Average target$98.38+16.43% vs. price

Buy 8 · Hold 5 · Sell 2 · Buy

TickerLandia Fingerprint: Solventum

Compared with similar companies: very low financial strength and very low growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 888 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Solventum is pricier than similar companies

Solventum's P/E (trailing 12 months): 94.9, +181% against the median of a group of 9 similar companies (33.8).

Compared with 9 similar companies

Solventum's metrics compared with similar companies
MetricSolventumPosition in the groupBand
P/E (trailing 12 months)94.9High
Forward P/E11.2Low
Operating margin5.9%Low
ROE3.2%Low
Debt/equity1.10High

Grey band: the middle half of the group; tick: the median; dot: Solventum. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$1.95B

Latest quarter · Q3 2026

Net income

-$12M

Latest quarter · Q3 2026

Quarterly net margin

-0.6%

Latest quarter · Q3 2026

Numbers and valuation

Full valuation
Market cap
$14.36B
P/E
94.9
EPS
$0.89
Volume
658.35K
Daily trading
€97.29M
Dividend yield
0.00%

How Solventum is changing

All results
  • Revenue grew 2.7% a year on average over the last 5 years

  • Operating margin fell from 20.8% to 8.1%

  • Free cash flow equal to 72% of net income

Returns

Solventum returns

$1,000 invested in Solventum 1 year ago, on November 20, 2025, would be worth $1,063 today: +6.28% in total, +6.28% per year. This is the price return only: dividends are excluded.

PeriodSolventumS&P 500$1,000 becomes
1 month−2.19%−10.40%$978
6 months+10.99%−7.03%$1,110
Year to date+6.64%+0.95%$1,066
1 year+6.28%+5.68%$1,063

Over the last 6 months it has done better than 50% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Solventum: technical analysis

Solventum shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 8.6% below its all-time closing high ($92.44, September 3, 2026).

Trend
No clear trend
RSI (14 sessions)
42
Between 30 and 70
vs 200-session average
+6.84%

Support and resistance

Price areas where Solventum has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. Resistance$92.49+9.45%2 touches, last on November 6, 2026
  2. Resistance$89.24+5.61%5 touches, last on October 15, 2026
  3. Resistance$86.45+2.30%2 touches, last on September 18, 2026
  4. Last price$84.50
  5. Support$83.01−1.76%4 touches, last on October 13, 2026
  6. Support$80.47−4.77%5 touches, last on October 30, 2026
  7. Support$77.61−8.15%3 touches, last on July 23, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.64
Volatility (60 sessions, annualised)
26.2%
Largest fall in the last year
−27.46%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

The company

Solventum and its competitors

Healthcare systems, dental professionals, patients and original equipment manufacturers in the United States and abroad are the customers Solventum serves. The company develops, manufactures and sells wound care products such as negative pressure wound therapy and advanced wound dressings, surgical supplies, sterilization assurance and temperature management solutions, and medical tapes and wraps.

Headquarters
Eagan, United States
Employees
20,584
Founded
2023
Chief executive
Bryan Hanson
Solventum and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
SolventumSOLV$14.36B5.9%94.9+10.99%
Baxter InternationalBAX$13.14B7.6%—+35.27%
Cooper CompaniesCOO$11.2B12.9%20.2−4.65%
Align TechnologyALGN$10.94B19.6%22.6−5.03%
RepligenRGEN$10.89B8.1%—+46.60%
AvantorAVTR$10.06B8.0%29.7+88.32%

Same industry or related industries, similar size. Compare Solventum with its competitors · Full profile